Active-ingredient Dossier
Rabeprazole Sodium
Active-ingredient Dossier for Rabeprazole Sodium (proton pump inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: RABEPRAZOLE SANDOZ
- Brand: PARIET
- Brand: APO-RABEPRAZOLE
- Brand: Parbezol
- Brand: RABEPRAZOLE
- Brand: RABEPRAZOLE VIATRIS
- Therapeutic area: Gastroenterology
What is
Rabeprazole Sodium Rabeprazole Sodium is a proton pump inhibitor.
Australian brands containing
Rabeprazole Sodium — RABEPRAZOLE SANDOZ — PARIET — APO-RABEPRAZOLE — Parbezol — RABEPRAZOLE — RABEPRAZOLE VIATRIS — RABEPRAZOLE-WGR — RAZIT — ZABEP
Therapeutic areas
Rabeprazole Sodium is registered in Infectious Disease (13 brands) and Gastroenterology (1 brand).
Sponsor landscape
The ingredient is marketed by nine sponsors: Arrotex Pharmaceuticals, Sun Pharma, Medis Pharma, Janssen-Cilag, Bafna Pharmaceuticals, and Sandoz.
PBS and regulatory activity
One brand containing Rabeprazole Sodium has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 March 2024, and no AusPARs are on record.